Condition

Resectable NSCLC clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Neoadjuvant fulzerasib followed by sintilimab plus platinum-doublet chemotherapy for resectable KRAS G12C-mutant NSCLC

  This will test whether giving fulzerasib first, then sintilimab with platinum-doublet chemotherapy before surgery helps people with resectable KRAS G12C‑mutant stage IB–IIIA non‑small cell lung cancer.

  Recruiting Phase 2 The First Affiliated Hospital of Guangzhou Medical University · Beijing and 2 other locations · NCT07492342

• Tislelizumab plus thoracic radiotherapy before surgery for resectable non-small cell lung cancer

  This will test whether giving tislelizumab together with thoracic radiotherapy before surgery helps people with resectable NSCLC.

  Recruiting Phase 2 Northern Jiangsu People's Hospital · Yangzhou, Jiangsu · NCT07050056

Related topics

Quick answers

How many Resectable NSCLC clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →